abstract |
The present invention includes miRNA profiles and Type I IFN / IFNα inducible PD marker profiles in inflammatory or autoimmune disorders such as myositis. The profile can also be used, for example, to treat a patient, to monitor a patient's disease progression, and to diagnose or provide a prediction for a patient with an inflammatory or autoimmune disorder. |